Source: Professor Erwin Loh A minor scientific clarification: there is no recognized hormone, receptor, or therapeutic class called GLP-3. Retatrutide is a triple receptor agonist targeting the GLP-1 receptor, GIP receptor, and glucagon receptor
Do those three things and the drug does exactly what it is supposed to do
Key highlights Heartburn is a potential side effect of semaglutide (Ozempic and Wegovy) that typically occurs when you start treatment or increase the dose during the titration phase
Cold sensations have been reported anecdotally by some trial participants, but precise incidence figures are not available from published Phase 2 data
Read guide Eligibility BMI criteria, contraindications, and screening
Upadacitinib in Crohns disease